Skip to main content
Market intelligence
PRQRSector not reported

ProQR Therapeutics N.V insider activity

In the last 90 days, 2 corporate insiders purchased $1,342,385 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$1,342,385
Corporate buyers
2
Latest transaction
Jul 31, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 31, 2026Boer Daniel Anton deChief Executive OfficerOpen Market Purchase200,000$1.77$353,960
Jul 17, 2026Bart FiliusCorporate insiderOpen Market Purchase150,000$1.72$257,925
Jul 9, 2026Boer Daniel Anton deChief Executive OfficerOpen Market Purchase150,000$1.74$261,000